Some say that the NNT or number needed to treat, a metric of therapeutic benefit, is harder for patients to understand than other metrics. The evidence on this is thin and conflicting, however. More in my AcademyHealth post.
Austin Frakt, PhD, is co-Editor-in-Chief of The Incidental Economist and tweets at @afrakt. His day job is Director of the Partnered Evidence-based Policy Resource Center at the Boston VA Healthcare System, U.S. Department of Veterans Affairs. He is also a Professor with the Department of Health Law, Policy and Management at the Boston University’s School of Public Health, a Principal Research Scientist with the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health, and Editor-in-Chief of the journal Health Services Research.